Evaluation of adjuvant doxorubicin-based chemotherapy for the treatment of feline mammary carcinoma

Journal of Veterinary Internal Medicine

Volumn 23, Issue 1, 2009, Pages 123-129

  McNeill, C J ^a   Sorenmo, K U ^a   Shofer, F S ^a   Gibeon, L ^a   Durham, A C ^b   Barber, L G ^c   Baez, J L ^d   Overley, B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c TUFTS UNIVERSITY   (United States)

^d Center for Animal Referral and Emergency Services   (United States)

Author keywords

Adriamycin; Breast; Cancer; Cat; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADJUVANT CHEMOTHERAPY; ANIMAL; ARTICLE; CAT; CAT DISEASE; COHORT ANALYSIS; EXPERIMENTAL NEOPLASM; FEMALE; MALE; RETROSPECTIVE STUDY;

ANIMALS; ANTINEOPLASTIC AGENTS; CAT DISEASES; CATS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; MALE; MAMMARY NEOPLASMS, ANIMAL; RETROSPECTIVE STUDIES;

ANIMALIA; FELIDAE;

EID: 61349151144     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0244.x     Document Type: Article

References (32)

1. Dorn CR, Taylor DO, Frye FL, et al. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. I. Methodology and description of cases. J Natl Cancer Inst 1968;40:295-305.
2. Dorn CR, Taylor DO, Schneider R, et al. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 1968;40:307-318.
3. Hayes Jr HM, Milne KL, Mandell CP. Epidemiological features of feline mammary carcinoma. Vet Rec 1981;108:476-179.
4. Viste JR, Myers SL, Singh B, et al. Feline mammary adenocarcinoma: Tumor size as a prognostic indicator. Can Vet J 2002; 43:33-37.
5. Weijer K, Head KW, Misdorp W, et al. Feline malignant mammary tumors. I. Morphology and biology: Some comparisons with human and canine mammary carcinomas. J Natl Cancer Inst 1972;49:1697-1704.
6. Weijer K, Hart AA. Prognostic factors in feline mammary carcinoma. J Natl Cancer Inst 1983;70:709-716.
7. Bostock DE. Canine and feline mammary neoplasms. Br Vet J 1986;142:506-515.
8. Hayden DW, Nielsen SW. Feline mammary tumours. J Small Anim Pract 1971;12:687-698.
9. Hayes AA, Mooney S. Feline mammary tumors. Vet Clin North Am Small Anim Pract 1985;15:513-520.
10. Patnaik AK, Liu SK, Hurvitz AI, et al. Nonhematopoietic neoplasms in cats. J Natl Cancer Inst 1975;54:855-860.
11. Hahn KA, Bravo L, Avenell JS. Feline breast carcinoma as a pathologic and therapeutic model for human breast cancer. In Vivo 1994;8:825-828.
12. Ito T, Kadosawa T, Mochizuki M, et al. Prognosis of malignant mammary tumor in 53 cats. J Vet Med Sci 1996;58:723-726.
13. Waters DJ, Honeckman A, Cooley DM, et al. Skeletal metastasis in feline mammary carcinoma: Case report and literature review. J Am Anim Hosp Assoc 1998;34:103-108.
14. Misdorp W, Romijn A, Hart AA. Feline mammary tumors: A case-control study of hormonal factors. Anticancer Res 1991;11: 1793-1797.
15. Misdorp W, Romijn A, Hart AA. The significance of ovariectomy and progestagens in the development of mammary carcinoma in cats. Tijdschr Diergeneeskd 1992;117:2-4.
16. Overley B, Shofer FS, Goldschmidt MH, et al. Association between ovariohysterectomy and feline mammary carcinoma. J Vet Intern Med 2005;19:560-563.
17. MacEwen EG, Hayes AA, Harvey HJ, et al. Prognostic factors for feline mammary tumors. J Am Vet Med Assoc 1984;185:201-204.
18. Skorupski KA, Overley B, Shofer FS, et al. Clinical characteristics of mammary carcinoma in male cats. J Vet Intern Med 2005;19:52-55.
19. Novosad CA, Bergman PJ, O'Brien MG, et al. Retrospective evaluation of adjunctive doxorubicin for the treatment of feline mammary gland adenocarcinoma: 67 cases. J Am Anim Hosp Assoc 2006;42:110-120.
20. Castagnaro M, Casalone C, Bozzetta E, et al. Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas. J Comp Pathol 1998;119:263-275.
21. De las Mulas JM, van Niel M, Millan Y, et al. Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: Comparison with biochemical assay. Domest Anim Endocrinol 2000;18:111-125.
22. Hamilton JM, Else RW, Forshaw P. Oestrogen receptors in feline mammary carcinomas. Vet Rec 1976;99:477-479.
23. Millanta F, Calandrella M, Citi S, et al. Overexpression of HER-2 in feline invasive mammary carcinomas: An immunohisto- chemical survey and evaluation of its prognostic potential. Vet Pathol 2005;42:30-34.
24. Millanta F, Lazzeri G, Vannozzi I, et al. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas. Vet Pathol 2002;39:690-696.
25. Castagnaro M, Casalone C, Ru G, et al. Argyrophilic nucleolar organiser regions (AgNORs) count as indicator of post-surgical prognosis in feline mammary carcinomas. Res Vet Sci 1998;64:97-100.
26. Preziosi R, Sarli G, Benazzi C, et al. Multiparametric survival analysis of histological stage and proliferative activity in feline mammary carcinomas. Res Vet Sci 2002;73:53-60.
27. Preziosi R, Sarli G, Benazzi C, et al. Detection of proliferating cell nuclear antigen (PCNA) in canine and feline mammary tumours. J Comp Pathol 1995;113:301-313.
28. Millanta F, Citi S, Della Santa D, et al. COX-2 expression in canine and feline invasive mammary carcinomas: Correlation with clinicopathological features and prognostic molecular markers. Breast Cancer Res Treat 2006;98:115-120.
29. Castagnaro M, De Maria R, Bozzetta E, et al. Ki-67 index as indicator of the post-surgical prognosis in feline mammary carcinomas. Res Vet Sci 1998;65:223-226.
30. Jeglum KA, deGuzman E, Young KM. Chemotherapy of advanced mammary adenocarcinoma in 14 cats. J Am Vet Med Assoc 1985;187:157-160.
31. Mauldin GN, Matus RE, Patnaik AK, et al. Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats. J Vet Intern Med 1988;2:60-65.
32. Lana SE, Rutteman GR, Withrow SJ. Tumors of the mammary gland. In: Withrow SJ. Vail DM, eds. Withrow & MacEwen's Small Animal Clinical Oncology, 4th ed. St Louis, MO: Saunders Elsevier, 2007:619-636.